期刊文献+

补肾通络方对衰老大鼠血清T水平及Leydig细胞数目的影响 被引量:4

下载PDF
导出
摘要 目的:观察补肾通络方对雄激素部分缺乏大鼠血清睾酮(T)水平及睾丸间质(Leydig)细胞数目的影响。方法:采用自然衰老大鼠模型,补肾通络方低、中、高剂量组干预模型大鼠,放免法检测各组大鼠T、黄体生成素(LH)的变化;HE染色观察Leydig数目变化;免疫组化法观察Leydig细胞StAR阳性表达。结果:补肾通络方干预后能提高自然衰模型大鼠T水平(P<0.05),对LH影响不明显(P>0.05)。补肾通络方高、中剂量组能增加雄激素部分缺乏大鼠Leydig细胞数目(P<0.05)。结论:补肾通络方能提高模型大鼠血清T水平,增加Leydig细胞数目是其作用机制之一。
出处 《河南中医》 2012年第7期833-835,共3页 Henan Traditional Chinese Medicine
基金 苏州市2010科技发展计划项目(编号:SYS201055)
  • 相关文献

参考文献5

  • 1李宏军,谷翊群.男性迟发性性腺功能减退症的发病机制与流行病学[J].国际生殖健康/计划生育杂志,2011,30(1):10-13. 被引量:31
  • 2Mahmoud A, Comhaire FI-I. Mechanisms of disease: late - onsethypgonadism[J].Nat Clin Pract Uro1,2006,3 (8) :430- 438.
  • 3Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB. Age trends in the level of serum testosterone and other hormones in middle -aged men:longi- tudinal results from the Massachusetts male aging study [ J ]. Clin Endocrinol Metab ,2002,87 ( 2 ) :589 - 598.
  • 4王启荣,杨则宜.类固醇激素合成急性调控蛋白(StAR)与睾酮的生物合成[J].中国运动医学杂志,2004,23(5):591-595. 被引量:8
  • 5Chen H, Hardy MP, Huhtaniemi I, Zirkin BR. Age- related de- creased Leydig cell testosterone production in the Brown Norway rat [J]. J Androl,1994,15(6) :551 -557.

二级参考文献66

  • 1申素琪,徐晓燕,蔡瑞芬,童建孙.江苏省3551例中老年男性健康调查[J].中华男科学杂志,2005,11(6):438-441. 被引量:45
  • 2Schneider G, Nienhaus K, Gromoll J, et al. Aging males'symptoms in relation to the genetically determined androgen receptor CAG polymorphism, sex hormone levels and sample membership [J]. Psyehoneuroendoerinology,2010, 35(4):578-587.
  • 3Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males[J]. Int J Androl,2009,32( 1 ) : 1-10.
  • 4Wylie K, Froggatt N. Late onset hypogonadism, sexuality and fertility[J]. Hum Fertil(Camb),2010,13(3 ): 126-133.
  • 5Bassil N, Morley JE. Late-life onset hypogonadism: a review[J]. Clin Geriatr Med,2010,26(2):197-222.
  • 6Permpongkosol S, Tantirangsee N, Ratana-Olarn K. Treatment of 161 men with symptomatic late onset hypogonadism with long- acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints [J]. J Sex Med, 2010,7( 11 ) : 3765-3774.
  • 7Amano T, Imao T, Takemae K, et al. Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients [J]. Aging Male, 2010, 13(4) :242-246.
  • 8Tsujimura A, Takada S, Matsuoka Y, et al. Clinical trial of treatment with saikokaryukotsuboreito for eugonadal patients with late-inset hypogonadism-related symptoms [J]. Aging Male,2008, 11 ( 2 ) :95 -99.
  • 9Brunton SA, Sadovsky R. Late-onset male hypogonadism and testosterone replacement therapy in primary care[J]. J Faro Pract, 2010,59( 7 Suppl ):S 1-8.
  • 10Harkonen K, Huhtaniemi I, Makinen J, et al. The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men[J]. Int J Androl,2003, 26( 3 ):187-194.

共引文献37

同被引文献116

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部